Obesity promotes breast epithelium DNA damage in women carrying a germline mutation in BRCA1 or BRCA2
Science Translational Medicine · 2023
DOI: 10.1126/scitranslmed.ade1857 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, 2023. Verfasst von Priya Bhardwaj und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA. Hauptthemen laut MEDLINE: Mammary Glands, Human, Breast Neoplasms. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Obesity, defined as a body mass index (BMI) ≥ 30, is an established risk factor for breast cancer among women in the general population after menopause. Whether elevated BMI is a risk factor for women with a germline mutation in BRCA1 or BRCA2 is less clear because of inconsistent findings from epidemiological studies and a lack of mechanistic studies in this population. Here, we show that DNA damage in normal breast epithelia of women carrying a BRCA mutation is positively correlated with BMI and with biomarkers of metabolic dysfunction. In addition, RNA sequencing showed obesity-associated alterations to the breast adipose microenvironment of BRCA mutation carriers, including activation of estrogen biosynthesis, which affected neighboring breast epithelial cells. In breast tissue explants cultured from women carrying a BRCA mutation, we found that blockade of estrogen biosynthesis or estrogen receptor activity decreased DNA damage. Additional obesity-associated factors, including leptin and insulin, increased DNA damage in human BRCA heterozygous epithelial cells, and inhibiting the signaling of these factors with a leptin-neutralizing antibody or PI3K inhibitor, respectively, decreased DNA damage. Furthermore, we show that increased adiposity was associated with mammary gland DNA damage and increased penetrance of mammary tumors in Brca1 +/− mice. Overall, our results provide mechanistic evidence in support of a link between elevated BMI and breast cancer development in BRCA mutation carriers. This suggests that maintaining a lower body weight or pharmacologically targeting estrogen or metabolic dysfunction may reduce the risk of breast cancer in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA.
- Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
- Department of Medical Laboratory Technology, College of Applied Medical Science, Taibah University, Medina 42353, Saudi Arabia.
- Center for Advanced Biomolecular Recognition, Korea Institute of Science and Technology, Seoul 02792, Korea.
- Computational Biology Service Unit of Life Sciences Core Laboratories Center, Cornell University, Ithaca, NY 14853, USA.
- Department of Population Health Sciences, Weill Cornell Medicine, New York, NY 10065, USA.
ORCID-Profile: Priya Bhardwaj, Neil M Iyengar, Heba Zahid, Man Ho Choi, Qi Sun, Catherine Liu, Phoebe Piloco, Monica Acosta, Olivier Elemento, Lukas E Dow, Sofya Oshchepkova, Michael Pollak, Xi Kathy Zhou, Benjamin D Hopkins, Ashley M Laughney, Melissa K Frey, Monica Morrow, Jason A Spector, Lewis C Cantley, Kristy A Brown
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- NCATS NIH HHS
Zitieren
APA
Bhardwaj, P., Iyengar, N. M., Zahid, H., Carter, K. M., Byun, D. J., Choi, M. H., Sun, Q., Savenkov, O., Louka, C., Liu, C., Piloco, P., Acosta, M., Bareja, R., Elemento, O., Foronda, M., Dow, L. E., Oshchepkova, S., Giri, D. D., Pollak, M., …, & Brown, K. A. (2023). Obesity promotes breast epithelium DNA damage in women carrying a germline mutation in BRCA1 or BRCA2. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.ade1857
Vancouver
Bhardwaj P, Iyengar NM, Zahid H, Carter KM, Byun DJ, Choi MH, et al. Obesity promotes breast epithelium DNA damage in women carrying a germline mutation in BRCA1 or BRCA2. Science Translational Medicine. 2023. doi:10.1126/scitranslmed.ade1857
BibTeX
@article{Bhardwaj2023,
author = {Bhardwaj, Priya and Iyengar, Neil M and Zahid, Heba and Carter, Katharine M and Byun, Dong Jun and Choi, Man Ho and Sun, Qi and Savenkov, Oleksandr and Louka, Charalambia and Liu, Catherine and Piloco, Phoebe and Acosta, Monica and Bareja, Rohan and Elemento, Olivier and Foronda, Miguel and Dow, Lukas E and Oshchepkova, Sofya and Giri, Dilip D and Pollak, Michael and Zhou, Xi Kathy and Hopkins, Benjamin D and Laughney, Ashley M and Frey, Melissa K and Ellenson, Lora Hedrick and Morrow, Monica and Spector, Jason A and Cantley, Lewis C and Brown, Kristy A},
title = {Obesity promotes breast epithelium DNA damage in women carrying a germline mutation in BRCA1 or BRCA2},
journal = {Science Translational Medicine},
year = {2023},
doi = {10.1126/scitranslmed.ade1857}
}
EUVIMED